Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.

EuroMOMO Excess mortality respiratory infections surveillance

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Apr 2024
Historique:
medline: 12 4 2024
pubmed: 12 4 2024
entrez: 12 4 2024
Statut: ppublish

Résumé

Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7-98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.

Identifiants

pubmed: 38606570
doi: 10.2807/1560-7917.ES.2024.29.15.2400178
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Sarah K Nørgaard (SK)

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Jens Nielsen (J)

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Anne Christine Nordholm (AC)

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Lukas Richter (L)

Austrian Agency for Health and Food Safety, Vienna, Austria.

Alena Chalupka (A)

Austrian Agency for Health and Food Safety, Vienna, Austria.

Natalia Bustos Sierra (NB)

Sciensano, Brussels, Belgium.

Toon Braeye (T)

Sciensano, Brussels, Belgium.

Maria Athanasiadou (M)

Health Monitoring Unit, Cyprus Ministry of Health, Nicosia, Cyprus.

Theodore Lytras (T)

School of Medicine, European University Cyprus, Nicosia, Cyprus.

Gleb Denissov (G)

National Institute for Health Development, Tallinn, Estonia.

Oskari Luomala (O)

Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Anne Fouillet (A)

Santé publique France, Saint-Maurice, France.

Isabelle Pontais (I)

Santé publique France, Saint-Maurice, France.

Matthias An der Heiden (M)

Robert Koch Institute, Berlin, Germany.

Benedikt Zacher (B)

Robert Koch Institute, Berlin, Germany.

Alina Weigel (A)

Hessisches Landesamt für Gesundheit und Pflege, Dillenburg, Germany.

Ivo Foppa (I)

Hessisches Landesamt für Gesundheit und Pflege, Dillenburg, Germany.

Kassiani Gkolfinopoulou (K)

Hellenic National Public Health Organization, Athens, Greece.

Ioannis Panagoulias (I)

Hellenic National Public Health Organization, Athens, Greece.

Anna Paldy (A)

National Center for Public Health and Pharmacy, Budapest, Hungary.

Tibor Malnasi (T)

National Center for Public Health and Pharmacy, Budapest, Hungary.

Lisa Domegan (L)

Health-Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.

Eva Kelly (E)

Health-Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.

Naama Rotem (N)

Central Bureau of Statistics, Jerusalem, Israel.

Oksana Rakhlin (O)

Central Bureau of Statistics, Jerusalem, Israel.

Francesca K de'Donato (FK)

Department of Epidemiology Lazio Regional Health System - ASL Roma 1, Rome, Italy.

Chiara Di Blasi (C)

Department of Epidemiology Lazio Regional Health System - ASL Roma 1, Rome, Italy.

Patrick Hoffmann (P)

Health Directorate, Luxembourg, Luxembourg.

Telma Velez (T)

Health Directorate, Luxembourg, Luxembourg.

Kathleen England (K)

Directorate for Health Information and Research, Pieta, Malta.

Neville Calleja (N)

Directorate for Health Information and Research, Pieta, Malta.

Liselotte van Asten (L)

Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Femke Jongenotter (F)

Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Ana Paula Rodrigues (AP)

Department of Epidemiology, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.

Susana Silva (S)

Department of Epidemiology, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.

Petra Klepac (P)

Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.

Diana Gomez-Barroso (D)

National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.

Inmaculada Leon Gomez (IL)

National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.

Ilias Galanis (I)

Public Health Agency of Sweden, Stockholm, Sweden.

Ahmed Farah (A)

Public Health Agency of Sweden, Stockholm, Sweden.

Rolf Weitkunat (R)

Federal Statistical Office, Neuchâtel, Switzerland.

Katarina Fehst (K)

Federal Statistical Office, Neuchâtel, Switzerland.

Nick Andrews (N)

UK Health Security Agency, London, United Kingdom.

Tom Clare (T)

UK Health Security Agency, London, United Kingdom.

Declan T Bradley (DT)

Public Health Agency, Northern Ireland, United Kingdom.

Mark G O'Doherty (MG)

Public Health Agency, Northern Ireland, United Kingdom.

Naoma William (N)

Public Health Scotland, Glasgow, United Kingdom.

Mark Hamilton (M)

Public Health Scotland, Glasgow, United Kingdom.

Bolette Søborg (B)

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Tyra G Krause (TG)

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Nick Bundle (N)

European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Lasse S Vestergaard (LS)

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Classifications MeSH